Takhzyro 300mg/2ml (Lanadelumab PFS) 300mg/2ml

Takhzyro 300mg/2ml (Lanadelumab) is a prescription injectable for hereditary angioedema (HAE) management. This pre-filled syringe formulation provides targeted therapy for acute attacks and prophylaxis. Store refrigerated between 2-8°C to maintain potency.

Strength

300mg/2ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Takeda Pharma

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lanadelumab is used to prevent hereditary angioedema (HAE) attacks in adults and adolescents. It works by targeting kallikrein to reduce bradykinin production, helping control swelling and pain associated with HAE episodes. This medication is not intended for acute attacks but for regular prevention.

Side Effects

Users may experience injection site reactions such as redness or pain. Some individuals report mild headaches or dizziness after administration. These effects are typically temporary and resolve without intervention. Consistent use helps maintain steady protection against HAE symptoms.

Precautions & Warnings

Keep this medication refrigerated at 2-8°C and protect it from light. Do not freeze or shake the pre-filled syringe. Before use, allow the syringe to reach room temperature for 15-30 minutes. Always check the liquid for particles or discoloration before injecting.

Avoid Interactions

Limited data exists on drug interactions with lanadelumab. No formal studies have evaluated its interaction with other medications. Exercise caution when combining with other injectable therapies. Consult a healthcare provider before starting any new treatment.

Frequently Asked Questions

Takhzyro 300mg/2ml is used to prevent hereditary angioedema (HAE) attacks in adults and adolescents.

Store Takhzyro 300mg/2ml refrigerated between 2-8°C and protect it from light.

No, Takhzyro 300mg/2ml is for prevention only and not for treating acute HAE attacks.

Common side effects may include injection site reactions, headaches, or dizziness.

Yes, Takhzyro 300mg/2ml is a prescription medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.